Affiliation:
1. Department of Obstetrics and Gynecology, School of Medicine, Gifu University, Japan.
Abstract
Many cephalosporin antibiotics have recently been invented and attempts have been made to use them clinically. The choice of which of these drugs should be used has been difficult in gynecology. The efficacies of these drugs depend on their antibacterial spectra, potencies, and concentrations in tissues. This study was designed to investigate the pharmacokinetics of various cephem antibiotics in the exudate of the retroperitoneal space that is formed after radical hysterectomy and pelvic lymphadenectomy. These cephem antibiotics were cefoxitin, cefotiam, cefotetan, cefpiramide, cefminox, cefotaxime, ceftizoxime, cefoperazone, cefmenoxime, cefbuperazone, ceftazidime, cefpimizole, flomoxef, and cefuzonam. The maximum concentrations after administration of a 1-g dose in the exudate of the pelvic retroperitoneal space were 37.9 micrograms/ml with cefminox, 30.3 micrograms/ml with cefpimizole, 21.6 micrograms/ml with flomoxef, 21.5 micrograms/ml with ceftazidime, and 17.6 micrograms/ml with cefbuperazone, which were relatively high. When selecting antibiotics for prophylactic use against infections in the retroperitoneal space after radical hysterectomy and pelvic lymphadenectomy, on the basis of drug transfer, flomoxef, cefminox, cefbuperazone, ceftazidime, and cefpimizole were considered to be the drugs of first choice at a dose of 1 g.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference4 articles.
1. Komiya K. Y. Kikuchi and A. Tachlbana. 1982. Absorption distribution metabolism and excretion of cefotetan (YM 09330) a new broad spectrum cephamycin in experimental animals. Chemotherapy 30:(Suppl. 1):106-118.
2. Pharmacokinetics of cefpiramide (SM-1652), new broad-spectrum and long-acting cephalosporin, parenterally administered to laboratory animals;Matsui H.;Chemotherapy,1983
3. A pharmacokinetic model for simulating drug concentrations in the tissue or fluids and its application to antibiotics;Mizuta E.;Chem. Pharm. Bull.,1985
4. Studies on the protein binding of cefoperazone (T-1551);Saikawa I.;Chemotherapy,1980